Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Search: “behind the study”

We found 55 results for your search.

Oncotarget

Behind the Study: Metronomic Cyclophosphamide – Innate Immunity and Anti-Tumor Responses

February 1, 2021

Researcher Mary Janatpour describes the findings in a paper she helped author in Oncotarget titled, "Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate… read more

Oncotarget

Behind the Study: Empty SV40 Capsids Elicit Host Signaling Networks

January 25, 2021

Researcher Arieh Eden discusses a recent paper published in Oncotarget entitled, "Empty SV40 capsids increase survival of septic rats by eliciting numerous host signaling networks that participate in a number… read more

Oncotarget

Study Identifies Key Genetic Alterations and Biomarker for Blastic Plasmacytoid Dendritic Cell Neoplasm

July 7, 2025

“Our findings demonstrate that the mutational landscape of BPDCN is similar to that observed in other myeloid neoplasms, and we identified CCDC50 as a potential biomarker for this disease.” BUFFALO,… read more

Figure 1: Mechanisms of MCL-1 inhibitor-induced MCL-1 protein upregulation, stability, and induction of apoptosis.

Oncotarget

Decoding the Mechanism Behind MCL-1 Inhibitors: A Pathway to Understanding MCL-1 Protein Stability

June 28, 2023

“Taken together, the study provides novel insights into the regulation of MCL-1 expression by MCL1i, associated molecular changes and their implications.” BUFFALO, NY- June 28, 2023 – A new editorial… read more

Oncotarget

Testimonial: Dr. J. James Frost

October 15, 2021

Below is a transcript of the 2017 testimonial by Dr. J. James Frost, formerly of Johns Hopkins Department of Radiology, about his experience publishing the paper, “Symmetry and symmetry breaking in cancer: a foundational approach to… read more